In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Teleflex nets $395mm in public senior notes offering

Executive Summary

Critical care and surgical devices firm Teleflex Inc. (offers products for vascular access, respiratory and cardiac, anesthesia, general surgical, and urology procedures) netted $395mm through the public sale of $400mm of its 4.875% senior notes due 2026 at an issue price of 100%. The company will use about $393mm of the proceeds to repay a portion of outstanding debt under its revolving credit facility.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO
    • Nonconvertible Debt

Related Companies

UsernamePublicRestriction

Register